Rel-(3R,5S)-3,5-bis(2,4,6-tribromophenoxy)cyclopent-1-ene

Modify Date: 2024-09-03 23:25:24

Rel-(3R,5S)-3,5-bis(2,4,6-tribromophenoxy)cyclopent-1-ene structure
 Common Name Rel-(3R,5S)-3,5-bis(2,4,6-tribromophenoxy)cyclopent-1-ene
CAS Number 84598-98-1 Molecular Weight 725.7
Density N/A Boiling Point N/A
Molecular Formula C17H10Br6O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name Rel-(3R,5S)-3,5-bis(2,4,6-tribromophenoxy)cyclopent-1-ene

 Chemical & Physical Properties

Molecular Formula C17H10Br6O2
Molecular Weight 725.7

 Preparation

Brc1cc(Br)c(OC2C=CC(Oc3c(Br)cc(Br)cc3Br)C2)c(Br)c1
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here
Related Compounds: More...
1-(3,4-Dichlorophenyl)-3-{[1-(dimethylsulfamoyl)piperidin-4-yl]methyl}urea
2097903-72-3
4-{[(3,5-dimethyl-1,2-oxazol-4-yl)formamido]methyl}-N,N-dimethylpiperidine-1-carboxamide
2097918-79-9
3-(2-bromophenyl)-N-{[4-(furan-3-yl)phenyl]methyl}propanamide
2097921-54-3
methyl N-[4-({[4-(furan-3-yl)phenyl]methyl}sulfamoyl)phenyl]carbamate
2097914-93-5
5-[3-(Methylsulfanyl)pyrrolidine-1-carbonyl]-2-(trifluoromethyl)pyridine
2097863-10-8
3-Fluoro-5-[3-(methylsulfanyl)pyrrolidine-1-carbonyl]pyridine
2097889-77-3
2-(3-Methylidenepiperidine-1-carbonyl)-1,3-benzothiazole
2097915-13-2
1-[(1,3-dimethyl-1H-pyrazol-4-yl)methyl]-3-methylidenepiperidine
2097897-65-7
5-Chloro-2-(3-methoxypyrrolidin-1-yl)pyrimidine
2097919-00-9
3-Cyclopropyl-5-(3-methoxypyrrolidin-1-yl)-1,2,4-thiadiazole
2097903-86-9
Chemsrc provides CAS#:84598-98-1 MSDS, density, melting point, boiling point, structure, etc. Its name is Rel-(3R,5S)-3,5-bis(2,4,6-tribromophenoxy)cyclopent-1-ene>> amp version: Rel-(3R,5S)-3,5-bis(2,4,6-tribromophenoxy)cyclopent-1-ene

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved